Excellent FAQs and resources from Building Healthy Online Communities on the latest in mpox (formerly known as monkeypox) prevention, transmission, symptoms, and treatment. Updated regularly.
Since the first HPV vaccines were introduced in 2006, rates of cervical cancer and other HPV-related cancers have decreased in immunized populations. Family PACT will add HPV immunization as a benefit in July 2022 and will utilize guidelines developed by the CDC Advisory Committee of Immunization Practices (ACIP). This webinar will provide information about the effectiveness and safety of the HPV vaccine, review the current CDC recommendations for the use of the 9-valent HPV vaccine, and provide advice on how to have effective shared decision-making conversations with clients about being immunized. In addition, new Family PACT policies about coding and billing for HPV immunization services will be discussed. There will be ample time for your questions at the end of the presentation.
Learning Objectives:
• List 2 effective strategies for engaging with patients who have vaccine hesitancy
• Demonstrate a person-centered technique for providing a strong recommendation without coercion
• Describe the impact of HPV vaccination on the natural history of HPV
Expedited Partner Therapy (EPT) for Sexually Transmitted Infections: A Resource for California Health Care Providers
Expedited Partner Therapy (EPT) for Sexually Transmitted Infections: A Resource for California Health Care Providers
Expedited Partner Therapy (EPT) is the clinical practice of treating sex partners of patients diagnosed with treatable sexually transmitted infections (STIs) – including chlamydia, gonorrhea, and trichomoniasis – without the health care provider first examining the partner(s).
This document explains what EPT is and why clinicians in California should prescribe it. In-depth references are also provided.
Clinical Practice Alert: Syphilis Screening, Diagnosis, and Treatment
Clinical Practice Alert: Syphilis Screening, Diagnosis, and Treatment
Rates of syphilis have been rising in the US, including in California, which has resulted in a corresponding rise in the rates of congenital syphilis (CS). Fifteen percent of women of childbearing age diagnosed with syphilis are pregnant.
These trends mirror a sharp increase in all stages of syphilis among females, which increased more than 500 percent during the same period. Download the PDF to learn more.
This Clinical Practice Alert includes management of primary, secondary, and latent syphilis. It does not include screening and management of syphilis in people who are pregnant or the diagnosis and treatment of tertiary syphilis.
Home
Training STI Clinical Update Webinar – Neurosyphilis
STI Clinical Update Webinar – Neurosyphilis
Thursday, July 21, 2022, 11:30 AM – 1:00 PM (PDT)
The California Department of Public Health (CDPH) continues to see dramatic statewide increases in syphilis. Neurosyphilis, a syphilitic infection of the nervous system, poses a complex diagnostic and management challenge for providers caring for patients with syphilis. This webinar features Drs. Kathleen Jacobson, Chief of the CDPH Sexually Transmitted Diseases Control Branch and Sue Tuddenham, Assistant Professor of Medicine at the Johns Hopkins University School of Medicine, who will discuss the epidemiology, diagnosis and management of neurosyphilis.
Learning Objectives:
Review California and national epidemiology of neurosyphilis
Describe the pathophysiology of neurosyphilis
Delineate clinical diagnosis and management of patients with neurosyphilis
We offer live online, live in-person, and self-paced online trainings. View upcoming learning opportunities and see our library of clinical webinars and other self-paced tools below.
Should you need accommodation in order to participate in events, please contact captc@ucsf.edu.
Our engaging live online courses are interactive and require your presence during the workshops. If you need assistance, or are interested in utilizing AI tools to augment your participation, please reach out to us to address your needs at captc@ucsf.edu.
Let us know how we can support you. The best way to reach us is over email: captc@ucsf.edu. We can provide tailored consultation and capacity-building services around curriculum development, facilitation support, and other communications skills.
Please join us for a morning half-day STI Intensive offered in-person and virtually at no cost at the University of California, San Francisco at the ZSFG campus.
November 20, 2024 12:00PM-1:15PM (PST) 1.25 CME units at no cost. Drs. Kathleen Jacobson and Wyatt Hanft will provide a 1-hour virtual training focused on syphilis clinical presentation, screening/testing, diagnosis,…
November 12, 2024 12:30PM-2:00PM (PST) 1.5 CME units at no cost Presenter: Jenell Stewart, DO, MPH Guide evidence-based shared decision-making conversations with individual patients who were assigned female sex at…
The goal of this training is to prepare staff of local health departments to perform effective disease intervention (DI) interviews for mpox. This training aims to build on disease intervention…
Friday, October 4, 2024, at 10 am PDT In honor of DIS Recognition Day 2024, the CAPTC is celebrating the essential life-saving work of disease intervention professionals!
Special Guest: Stefan Madzar, PrEP & HIV Benefits Coordinator & Linkage Navigator at Magnet (San Francisco AIDS Foundation). Stefan will present an update on Magnet’s injectable PrEP program, including challenges,…
Presented by Drs. Kelly Johnson and Kurtis Mohr Learning Objectives Describe the varied clinical manifestations of primary and secondary syphilis in adults and adolescents Appropriately stage and treat syphilis in…
The goal of this training is to prepare staff of local health departments to perform effective disease intervention (DI) interviews for mpox. This training aims to build on disease intervention…
Presented by Dr. Kelly Johnson Learning Objectives: List common causes for genital ulcerative disease. Interpret results of traditional & reverse syphilis screening algorithms. Explain the clinical significance of changes in…
Thursday, March 14, 2024 9:00AM-1:00PM (PDT) 3.75 CME units at no cost This half-day, hybrid event will provide important updates in the field of sexual health to help providers strengthen…
STI Clinical Update Webinar – Introduction to Syphilis and Congenital Syphilis: A Phoenix IHS and CAPTC Event January 11, 2024 8:30AM-12:00PM (MST) Presented by CAPTC Clinical Faculty Please note: CME…
January 31, 2024 12:00PM-1:15PM (PST) 1.25 CME units at no cost Learning Objectives List at least 2 factors contributing to ongoing Bicillin L-A shortages Describe a framework for prioritizing Bicillin…
Presented by Drs. Kathleen Jacobson and Wyatt Hanft December 5, 2023 Learning Objectives: Apply California’s expanded syphilis screening recommendations. Describe the stages of syphilis and the recommended treatment and follow…
May 11, 2022
Over the last year, the Family PACT Program has added several new benefits. These include three new contraceptive methods, a diagnostic test for Mycoplasma genitalium, and modifications in STI treatments based on the 2021 CDC STI Treatment Guidelines. In this webinar, a description of the new benefits will be provided and the Family PACT policies that relate to their utilization will be discussed. There will be ample time to ask questions regarding these and other Family PACT benefits.
Learning Objectives:
Describe and explain the three new contraceptive methods and explain how to discuss the advantages and disadvantages of each with Family PACT clients
List three circumstances when the use of the diagnostic test for Mycoplasma genitalium is clinically indicated
Describe four modifications in STI treatments based on the 2021 CDC STI Treatment Guidelines
Speakers:
Michael Policar, MD, MPH Professor Emeritus, UCSF Senior Medical Advisor, CAPTC and California OFP Clinical Fellow, NFPRHA
Home
Training STI Clinical Update Webinar: Dermatologic Manifestations of STIs
STI Clinical Update Webinar: Dermatologic Manifestations of STIs
May 27, 2022
Presented by Ken Katz, MD
What you see is what they’ve got! Come learn about mucocutaneous signs and symptoms of sexually transmitted infections.
Learning Objectives
Evaluate mucocutaneous manifestations of STIs.
Apply knowledge about mucocutaneous manifestations of STIs to diagnosis and management of patients.
We use cookies to ensure that we give you the best experience on our website, but we also recognize the right to privacy. Please accept or disable cookies for this website.AcceptDisable